Clinical Trials

2,300 enrolled

Breast Neoplasms

NCT00757211 2013-08-26

Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom

6,000 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00757263 2013-08-26

Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00757614 2013-08-26

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

CNSDermatologicGastrointestinalGenitourinaryLymphoidOther hematologic neoplasm

14,000 enrolled

Uveal Melanoma, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Renal Cell, Craniopharyngioma, Esophageal Neoplasms, Hodgkin Disease, Kidney Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Meningeal Neoplasms, Neoplasms, Germ Cell and Embryonal, Pancreatic Neoplasms, Pinealoma, Lymphoma, T-Cell, Cutaneous, Lymphoma, AIDS-Related, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Nephroma, Mesoblastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT00757965 2013-08-26

Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00758056 2013-08-26

Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

Gynecologic

Endometrial Neoplasms

NCT00758173 2013-08-26

Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom

Genitourinary

Prostatic Neoplasms

NCT00896818 2013-08-26

Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends

Breast Neoplasms

NCT01217398 2013-08-26

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Phase 2 Unknown

35 enrolled

Dermatologic

Uveal Melanoma

NCT00514345 2013-08-12

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

300 enrolled

Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00536718 2013-08-12

Genetics of Women With Lobular Carcinoma in Situ of the Breast

3,000 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Lobular

NCT00672321 2013-08-12

Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma

2,774 enrolled

Dermatologic

Melanoma

NCT00693836 2013-08-12

Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT00897871 2013-08-12

Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer

60 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00900536 2013-08-12

DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE

Completed

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00935233 2013-08-12

Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers

6,000 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00893477 2013-08-02

GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Phase 2 Unknown

60 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular

NCT01653613 2013-07-10

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

Other hematologic neoplasm

400 enrolled

Leukemia

NCT00381901 2011-05-13

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

Phase 3 Completed

3,400 enrolled

Breast Neoplasms

NCT00897455 2011-03-23

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

10,000 enrolled

Breast Neoplasms

NCT01074398 2010-02-24

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182